R
Rajeev Chawla
Researcher at Columbia Asia
Publications - 46
Citations - 1201
Rajeev Chawla is an academic researcher from Columbia Asia. The author has contributed to research in topics: Diabetes mellitus & Type 2 Diabetes Mellitus. The author has an hindex of 10, co-authored 46 publications receiving 773 citations.
Papers
More filters
Journal ArticleDOI
Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
TL;DR: It is imperative to understand whether microvascular complications distinctly precede macrov vascular complications or do both of them progress simultaneously as a continuum to allow re-focusing on the clinical issues with a unifying perspective which can improve type 2 diabetes mellitus outcomes.
Journal ArticleDOI
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020.
TL;DR: The present paper presents a meta-analysis of 148 cases of type 2 diabetes patients treated at the UCMS-GTB Hospital in Ahmedabad over a 12-month period from May 2013 to March 2014 that showed clear trends in disease progression and in particular in cases of high blood pressure and insulin resistance.
Journal ArticleDOI
Indian guidelines on hypertension-IV (2019).
Siddharth N Shah,Y P Munjal,Sandhya A Kamath,Gurpreet S. Wander,Nihar Mehta,Sukumar Mukherjee,Ashok Kirpalani,Pritam Gupta,Hardik Shah,Ragini Rohatgi,Aspi R. Billimoria,M. Maiya,Mrinal Kanti Das,Kewal C. Goswami,Rajan Sharma,Mohan Rajapurkar,Rajeev Chawla,Banshi Saboo,Vivekanand Jha,Vivekanand Jha +19 more
TL;DR: The fourth edition of the Indian Guidelines on Hypertension (IGH-IV) is presented, incorporating recent changes in the diagnosis and management of hypertension, including change in definition of hypertension by the American College of Cardiology/American Heart Association (ACC/AHA), changes in target BP and new epidemiological data on hypertension and hypertension mediated organ damage (HMOD).
Journal ArticleDOI
Unproven Therapies for Diabetes and Their Implications
Jothydev Kesavadev,Banshi Saboo,Shaukat Sadikot,Ashok Kumar Das,Shashank Joshi,Rajeev Chawla,Hemant Thacker,Arun Shankar,Lakshmy Ramachandran,Sanjay Kalra +9 more
TL;DR: Patients should be asked about CAM use during patient assessment, guidelines in place based on clinical trial outcomes, and stricter regulations need to be enforced on CAM practices to ensure their safety and effectiveness.
Journal ArticleDOI
Correction to: RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
TL;DR: In the RSSDI-ESI Consensus Group, Dr Sanjay Bhadada’s name was inadvertently missed out as one of the members under the category “Diabetes and CVD”.